StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
VTGN

Vistagen Therapeutics, Inc.

VTGN Nasdaq Pharmaceutical Preparations EDGAR ↗
$0.25
+0.01 +2.08%

Key statistics

from XBRL data in SEC filings
Market cap
$10.1M
Revenue (TTM)
$1.27M
Net income (TTM)
-$69.7M
EPS (TTM)
$-1.83
P/E ratio
Dividend yield
Free cash flow
Cash
$30.8M
Total assets
$48.6M
Gross margin
52-week range
$0.20 – $5.14

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change; Regulation FD disclosure Jul 31, 2026 8-K Regulation FD disclosure; Other events Jun 30, 2026 8-K Director or officer change Jun 17, 2026 10-K Fiscal year ended 2026-03-31 Jun 15, 2026 8-K Results of operations (earnings release) Jun 15, 2026 8-K Other events Jun 9, 2026 8-K Director or officer change; Regulation FD disclosure May 19, 2026 8-K Other events May 12, 2026 8-K Other events May 8, 2026 8-K Other events Apr 28, 2026 8-K Director or officer change Apr 13, 2026 8-K Delisting notice or listing-rule failure Apr 2, 2026 8-K Director or officer change Mar 18, 2026 8-K Regulation FD disclosure Mar 16, 2026 8-K Other events Mar 11, 2026 8-K Director or officer change Feb 20, 2026 10-Q Quarter ended 2025-12-31 Feb 12, 2026 8-K Results of operations (earnings release) Feb 12, 2026 8-K Delisting notice or listing-rule failure Feb 6, 2026 8-K Regulation FD disclosure Jan 9, 2026 8-K Other events Dec 22, 2025 8-K Director or officer change; Regulation FD disclosure Dec 3, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Regulation FD disclosure Nov 4, 2025 8-K Director or officer change; Regulation FD disclosure Oct 29, 2025 8-K Director or officer change; Shareholder vote results Sep 15, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 7, 2025 8-K Director or officer change Jun 25, 2025 8-K Results of operations (earnings release); Other events Jun 17, 2025 10-K Fiscal year ended 2025-03-31 Jun 17, 2025 8-K Regulation FD disclosure Jun 2, 2025 8-K Other events Mar 6, 2025 10-Q Quarter ended 2024-12-31 Feb 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 13, 2025 8-K Other events Feb 5, 2025 8-K Other events Jan 14, 2025 8-K Other events Jan 13, 2025 8-K Regulation FD disclosure Dec 6, 2024